Concepedia

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

Stefan Wilop, Sabine von Hobe, Martina Crysandt, Albert Esser, R. Osieka, Edgar Jost

Journal of Cancer Research and Clinical Oncology · 2009 · 163 citations · 24 references

DOIFull text

Open access

Concepts

References

24

Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

Joan H. Schiller, David Harrington, Chandra P. Belani et al. · New England Journal of Medicine · 2002 · 5K citations

, , +7

COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER

J Oan H. S Chiller, D Avid H Arrington, C Handra P. B Elani et al. · 2002 · 3.7K citations

, , +11

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

Anthony F. Lever, David Hole, C. Gillis et al. · The Lancet · 1998 · 547 citations

, , +8

FDA Drug Approval Summary: Bevacizumab (Avastin®) Plus Carboplatin and Paclitaxel as First-Line Treatment of Advanced/Metastatic Recurrent Nonsquamous Non-Small Cell Lung Cancer

Martin H. Cohen, Joe Gootenberg, Patricia Keegan et al. · The Oncologist · 2007 · 400 citations

, , +14

Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth

Kimiyasu Egami, Toyoaki Murohara, Toshifumi Shimada et al. · Journal of Clinical Investigation · 2003 · 336 citations · Full text

, , +14